内分泌疾病与妊娠丢失:全国性队列研究
该研究基于丹麦全国366,539名有妊娠记录的女性,发现内分泌疾病与妊娠丢失强烈相关,且随妊娠丢失次数增加关联增强;父母或姐妹的内分泌疾病亦与妊娠丢失相关,提示共享遗传或环境因素。
要点
- 内分泌疾病与妊娠丢失相关,且随丢失次数增加关联增强。
- 首次妊娠后诊断内分泌疾病者,首次妊娠丢失关联更强。
- 家族内分泌疾病史独立于个人诊断与妊娠丢失相关。
核心结论
- 内分泌疾病与妊娠丢失强烈相关,且不依赖时间顺序。
- 随妊娠丢失次数增加,关联逐渐增强。
- 家族内分泌疾病独立于个人诊断与妊娠丢失相关,提示共享遗传或环境因素。
研究设计与样本
- 全国性人群队列研究,纳入366,539名1977-1993年出生的丹麦女性。
- 暴露为妊娠前后诊断的内分泌疾病,主要结局为22周前妊娠丢失次数。
- 采用多因素多项逻辑回归计算OR,调整母亲年龄和妊娠年份。
主要发现
- 56,618名女性(15%)诊断内分泌疾病。
- 未考虑时间顺序时,1次、2次、≥3次妊娠丢失的OR分别为1.15(95%CI 1.12-1.17)、1.30(95%CI 1.24-1.37)、1.81(95%CI 1.70-1.93)。
- 所有主要内分泌疾病均与妊娠丢失显著相关。
- 首次妊娠后诊断内分泌疾病者,首次妊娠丢失OR为1.24(95%CI 1.20-1.29),高于首次妊娠前诊断者的OR 1.11(95%CI 1.07-1.15)。
- 父母或姐妹内分泌疾病与妊娠丢失的OR分别为1.07(95%CI 1.05-1.09)和1.08(95%CI 1.03-1.13)。
关键数值与推荐
- 妊娠丢失定义为22周前妊娠丢失次数,分为0、1、2、≥3次。
- 内分泌疾病亚组包括甲状腺功能减退、甲状腺功能亢进、多囊卵巢综合征、1型和2型糖尿病、妊娠期糖尿病。
临床怎么用
- 对妊娠丢失女性应考虑针对性内分泌评估。
- 需进一步研究确定最佳筛查策略和时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate associations between endocrine diseases and pregnancy loss, including associations according to the number of pregnancy losses, temporal patterns, and familial clustering independent of the woman's own endocrine diagnosis. DESIGN: Nationwide population-based cohort study. SUBJECTS: A total of 366,539 Danish women born between 1977 and 1993 with documented pregnancies in the Danish national registers. EXPOSURE: Presence of endocrine disease diagnosed before or after pregnancy. Subgroup analyses of major endocrine diseases, including hypothyroidism, hyperthyroidism, polycystic ovary syndrome (PCOS), type 1 and 2 diabetes, and gestational diabetes. MAIN OUTCOME MEASURES: Pregnancy loss, defined as the number of pregnancy losses before 22 weeks of gestation (categorized as 0, 1, 2, or ≥3 losses) in association with endocrine disease. Multivariable multinomial logistic regression models calculated odds ratios (ORs) with 95% confidence intervals adjusted for maternal age and year of pregnancy. Additional analyses examined associations according to timing of endocrine disease diagnosis relative to the first pregnancy and evaluated familial clustering. RESULTS: Endocrine disease was diagnosed in 56,618 women (15%). In analyses that did not account for temporal order, endocrine disease showed progressively stronger associations with increasing number of pregnancy losses: OR 1.15 (95% CI: 1.12-1.17) for one, OR 1.30 (95% CI: 1.24-1.37) for two, and OR 1.81 (95% CI: 1.70-1.93) for three or more. All major endocrine diseases were significantly associated with pregnancy loss. Women diagnosed with an endocrine disease after their first pregnancy showed a stronger association with pregnancy loss in the first pregnancy (OR 1.24 [95% CI: 1.20-1.29]) than those diagnosed before the first pregnancy (OR 1.11 [95% CI: 1.07-1.15]). Familial endocrine disease in a parent or sister was also positively associated with pregnancy loss (OR 1.07 [95% CI: 1.05-1.09] and OR 1.08 [95% CI: 1.03-1.13], respectively), independent of the woman's own endocrine diagnosis. CONCLUSION: Endocrine diseases and pregnancy loss were strongly associated regardless of temporal order, with progressively stronger associations across increasing numbers of pregnancy losses, with significant familial clustering independent of personal diagnosis, suggesting shared genetic or environmental factors. Our findings support consideration of targeted endocrine evaluation in women with pregnancy loss. Further research should determine optimal screening strategies and timing.
引用
- Egerup P, Bliddal S, Feldt-Rasmussen U, et al. Endocrine disease and pregnancy loss-a nationwide cohort study. Fertil Steril. 2026. PMID: 42624192. doi:10.1016/j.fertnstert.2026.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。